Form 4 for CRVL CORVEL CORP
Accepted 2025-01-08 00:00:00 ET · period of report 2025-01-06 · accession 0001641248-25-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-01-08 | 2025-01-06 | CRVL | Combs Michael G | CEO, Pres | F - Tax | $109.03 | -7,947 | 48.2K | -14% | -$866.5K |
| DM | 2025-01-08 | 2025-01-06 | CRVL | Combs Michael G | CEO, Pres | M - OptEx | $35.11 | +14.0K | 50.5K | +39% | +$493.0K |
| DM | 2025-01-08 | 2025-01-06 | CRVL | Combs Michael G | CEO, Pres | M - OptEx | $109.03 | -14.0K | 501 | -97% | -$1.53M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-01-06 | F | D | 396 | $109.03 | 47,037 | D | — | — | |
| 2 | Common | Common Stock | 2025-01-06 | M | A | 5,499 | $39.83 | 46,440 | D | — | — | |
| 3 | Common | Common Stock | 2025-01-06 | M | A | 1,200 | $17.56 | 47,626 | D | — | — | |
| 4 | Common | Common Stock | 2025-01-06 | F | D | 1,745 | $109.03 | 46,426 | D | — | — | |
| 5 | Common | Common Stock | 2025-01-06 | F | D | 193 | $109.03 | 47,433 | D | — | — | |
| 6 | Common | Common Stock | 2025-01-06 | F | D | 2,008 | $109.03 | 44,432 | D | — | — | |
| 7 | Common | Common Stock | 2025-01-06 | F | D | 1,286 | $109.03 | 43,146 | D | — | — | |
| 8 | Common | Common Stock | 2025-01-06 | M | A | 7,344 | $34.44 | 50,490 | D | — | — | |
| 9 | Common | Common Stock | 2025-01-06 | F | D | 2,319 | $109.03 | 48,171 | D | — | — | |
| 10 | Derivative | Non-Qualified Stock Option (right to buy) | 2025-01-06 | M | D | 7,344 | $109.03 | 156 | D | $34.44 · — to 2026-02-04 | 7,344 Common Stock | (F2) Exercisable as to 25% of shares one year following grant date with the remaining shares exercisable in 36 equal monthly installments thereafter. |
| 11 | Derivative | Non-Qualified Stock Option (right to buy) | 2025-01-06 | M | D | 1,200 | $109.03 | 0 | D | $17.56 · — to 2025-04-30 | 1,200 Common Stock | (F2) Exercisable as to 25% of shares one year following grant date with the remaining shares exercisable in 36 equal monthly installments thereafter. |
| 12 | Derivative | Non-Qualified Stock Option (right to buy) | 2025-01-06 | M | D | 5,499 | $109.03 | 501 | D | $39.83 · — to 2026-05-06 | 5,499 Common Stock | (F2) Exercisable as to 25% of shares one year following grant date with the remaining shares exercisable in 36 equal monthly installments thereafter. |